HLA matching for simultaneous pancreaskidney transplantation in the United States: A multivariable analysis of the UNOS data

Clinical Nephrology

Volumn 57, Issue 1, 2002, Pages 27-37

  Mancini, M J ^a   Connors, Jr ^a   Wang, X Q ^a   Nock, S ^a   Spencer, C ^a   McCullough, C ^a   Lobo, P ^a   Isaacs, R ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

CREG; HLA; Matching; Minorities; Outcomes; Pancreas; SPK; Transplantation

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; GRAFT SURVIVAL; HEALTH CARE ORGANIZATION; HLA MATCHING; HUMAN; HUMAN TISSUE; HYPOTHESIS; INCIDENCE; ISCHEMIA; KAPLAN MEIER METHOD; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PANCREAS TRANSPLANTATION; REGRESSION ANALYSIS; RESOURCE ALLOCATION; TIME; TREATMENT OUTCOME; UNITED STATES;

EID: 0036147346     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP57027     Document Type: Article

References (45)

1. The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes
2. Simultaneous pancreas-kidney transplantation - The Bochum experience
3. The role of HLA in renal transplantation
4. Regression models and life tables
5. New approaches to donor crossmatching and successful transplantation of highly sensitized patients
6. An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation
7. Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys
8. Reversal of lesions of diabetic nephropathy after pancreas transplantation
9. Substantial benefits of tissue matching in renal transplantation
10. Proportional hazards tests and diagnostics based on weighted residuals
11. Pancreas transplantation in the United States (US) and non-US as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR)
12. Use of FK506 in pancreas transplantation
13. Predicting outcomes: Applied survival analysis and logistic regression
14. HLA matching
15. The impact of HLA mismatches on the survival of first cadaveric kidney transplants
16. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
17. Is HLA matching worthwhile in pancreatic transplantation?
18. Racial disparities in access for SPK transplantation in the United States
19. Pancreas transplantation restores epinephrine response and symptom recognition during hypoglycemia in patients with long-standing type I diabetes and autonomic neuropathy
20. Effects of pancreatic transplantation on diabetic neuropathy
21. Reduction of insulin resistance by combined - Kidney-pancreas transplantation in type 1 (insulin-dependent) diabetic patients
22. Long-term effects of pancreatic transplantation on diabetic neuropathy
23. Correlation of HLA matching with graft survival in patients with or without cyclosporine treatment
24. Preliminary analysis of HLA matching in pancreas and liver transplantation
25. Progression of diabetic retinopathy after pancreas transplantation
26. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus
27. Influence of simultaneous pancreas and kidney transplantation on renal graft survival
28. Epitope specificity of HLA class I alloantibodies
29. The effect of HLA-A,-B matching on cadaveric renal allograft rejection comparing public and private specificities
30. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type 1 diabetes mellitus and end-stage renal failure
31. DR matching improves cadaveric pancreas transplant results
32. Short-term and long-term effects of HLA matching in cadaveric pancreas transplantation
33. Experience with 500 simultaneous pancreas-kidney transplants
34. Living-related kidney transplant or simultaneous pancreas-kidney for diabetic renal failure?
35. A 10-year experience with 290 pancreas transplants at a single institution
36. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors
37. Equitable allocation of HLA-compatible kidneys for local pools and for minorities
38. Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regrafts
39. CREG matching for first kidney transplants performed by SEOPF centers between October 1987 and September 1995: An analysis of outcome and prospective benefit
40. The effect of HLA matching on kidney graft survival in separate post-transplantation intervals
41. Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy ten years after combined pancreas and kidney transplantation
42. The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy
43. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant